Disease: Camurati Engelmann disease- type 2
- About a case of Dysosto sis enchondralis epiphysaria (Ribbing's disease) of the type of early microepiphyses
- Acquired Chiari malformation secondary to hyperostosis of the skull: a case report and literature review
- An ENU-induced p.C225S missense mutation in the mouse Tgfb1 gene does not cause Camurati-Engelmann disease-like skeletal phenotypes
- Autosomal dominant osteosclerosis
- Hyperactive transforming growth factor-beta1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
- Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model
- Imaging features and differential diagnosis of multiple diaphyseal sclerosis: A case report and review of literature
- In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias
- Looking for the skeleton in the closet-rare genetic diagnoses in patients with diabetes and skeletal manifestations
- Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease
- Orthopedic Manifestations of Type I Camurati-Engelmann Disease
- Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation
- Reduced Dentin Matrix Protein Expression in Camurati-Engelmann Disease Transgenic Mouse Model
- Sclerosing bone disorders
- Significant Improvement of Clinical Symptoms, Bone Lesions, and Bone Turnover after Long-Term Zoledronic Acid Treatment in Patients with a Severe Form of Camurati-Engelmann Disease